Acromegaly, a rare chronic endocrine disorder caused by excess growth hormone, is seeing promising advances in treatment development
MRI is particularly valuable in pediatric care due to its non-invasive nature
Biocon will acquire the residual stake held by Mylan (Viatris) for a total consideration of US$ 815 million
VitiPure serves as essential solubilizers, emulsifiers, and bioavailability enhancers in drug formulations
The one-time CAR T cell infusion now becomes the first and only therapy of its kind cleared for this patient population
Ipca Laboratories receives three observations from USFDA for API facility at Tarapur
The topical fluralaner solution is cleared for the prevention and treatment of new world screwworm infestation
Valorum will advance the commercialization and distribution of Armlupeg in the United States
Excelsior aims to make reshoring affordable and strategic, shielding nations from geopolitical disruptions
Implementing PFAS testing in the early development stages allows medical device manufacturers to prepare for potential regulatory updates
Subscribe To Our Newsletter & Stay Updated
